AMICUS THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Amicus Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Amicus Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 26, 2024 was 297M shares, a 3.3% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 297M +9.47M +3.3% Jul 26, 2024 10-Q 2024-08-08
Q1 2024 296M +11.6M +4.08% Apr 25, 2024 10-Q 2024-05-09
Q4 2023 295M +12.7M +4.48% Feb 13, 2024 10-K 2024-02-28
Q3 2023 293M +12.3M +4.38% Oct 25, 2023 10-Q 2023-11-08
Q2 2023 287M +6.62M +2.36% Jul 26, 2023 10-Q 2023-08-08
Q1 2023 285M +4.41M +1.58% Apr 27, 2023 10-Q 2023-05-10
Q4 2022 283M Feb 13, 2023 10-K 2023-03-01
Q3 2022 281M +2.31M +0.83% Oct 25, 2022 10-Q 2022-11-07
Q2 2022 280M +13.9M +5.23% Jul 27, 2022 10-Q 2022-08-04
Q1 2022 280M +14.1M +5.3% Apr 27, 2022 10-Q 2022-05-10
Q3 2021 279M +18.1M +6.93% Oct 27, 2021 10-Q 2021-11-09
Q2 2021 267M +7.77M +3% Jul 27, 2021 10-Q 2021-08-05
Q1 2021 266M +8.4M +3.26% Apr 26, 2021 10-Q 2021-05-10
Q3 2020 261M +5.78M +2.27% Oct 26, 2020 10-Q 2020-11-05
Q2 2020 259M +4.16M +1.63% Jul 27, 2020 10-Q 2020-08-10
Q1 2020 258M +27.2M +11.8% Apr 27, 2020 10-Q 2020-05-07
Q3 2019 255M +65.5M +34.6% Oct 31, 2019 10-Q 2019-11-12
Q2 2019 255M +65.5M +34.6% Jul 30, 2019 10-Q 2019-08-08
Q1 2019 230M +42M +22.3% Apr 29, 2019 10-Q 2019-05-09
Q3 2018 189M +23M +13.8% Oct 29, 2018 10-Q 2018-11-05
Q2 2018 189M +24.6M +14.9% Jul 31, 2018 10-Q 2018-08-07
Q1 2018 188M +45.6M +31.9% Apr 30, 2018 10-Q 2018-05-09
Q3 2017 166M +23.9M +16.8% Oct 31, 2017 10-Q 2017-11-08
Q2 2017 165M +22.4M +15.8% Jul 25, 2017 10-Q 2017-08-07
Q1 2017 143M +15.9M +12.5% Apr 25, 2017 10-Q 2017-05-09
Q3 2016 142M +17.4M +14% Oct 28, 2016 10-Q 2016-11-07
Q2 2016 142M +23.5M +19.8% Jul 29, 2016 10-Q 2016-08-09
Q1 2016 127M +30.6M +31.8% Apr 26, 2016 10-Q 2016-05-03
Q4 2015 125M Feb 12, 2016 10-K 2016-02-29
Q3 2015 125M +45.6M +57.5% Oct 29, 2015 10-Q 2015-11-04
Q2 2015 119M +39.9M +50.7% Jul 29, 2015 10-Q 2015-08-05
Q1 2015 96.4M +32.1M +49.9% Apr 24, 2015 10-Q 2015-05-05
Q3 2014 79.3M +29.7M +59.8% Oct 31, 2014 10-Q 2014-11-06
Q2 2014 78.7M +29.1M +58.6% Jul 30, 2014 10-Q 2014-08-07
Q1 2014 64.3M +14.7M +29.6% Apr 28, 2014 10-Q 2014-05-05
Q3 2013 49.6M +182K +0.37% Oct 31, 2013 10-Q 2013-11-12
Q2 2013 49.6M +292K +0.59% Jul 31, 2013 10-Q 2013-08-07
Q1 2013 49.6M +3.26M +7.02% Apr 26, 2013 10-Q 2013-05-09
Q3 2012 49.4M +14.8M +42.7% Oct 26, 2012 10-Q 2012-11-06
Q2 2012 49.3M +14.7M +42.6% Aug 2, 2012 10-Q 2012-08-08
Q1 2012 46.4M Apr 26, 2012 10-Q 2012-05-11
Q3 2011 34.7M Oct 26, 2011 10-Q 2011-11-02
Q2 2011 34.6M Jul 28, 2011 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.